CONTRAVE is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Naltrexone Hydrochloride; Bupropion Hydrochloride.
| Product ID | 50090-2868_c5a82f8e-c627-4d42-8046-47c94ed56884 |
| NDC | 50090-2868 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CONTRAVE |
| Generic Name | Naltrexone Hydrochloride And Bupropion Hydrochloride |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-09-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA200063 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE |
| Active Ingredient Strength | 8 mg/1; mg/1 |
| Pharm Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2017-02-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA200063 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-02-15 |
| Marketing End Date | 2018-09-30 |
| Ingredient | Strength |
|---|---|
| NALTREXONE HYDROCHLORIDE | 8 mg/1 |
| SPL SET ID: | f074eeef-312c-4e7d-869d-79c24e0c514e |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43063-772 | Contrave | naltrexone hydrochloride and bupropion hydrochloride |
| 50090-2868 | CONTRAVE | naltrexone hydrochloride and bupropion hydrochloride |
| 50090-2945 | Contrave | naltrexone hydrochloride and bupropion hydrochloride |
| 51267-890 | Contrave | naltrexone hydrochloride and bupropion hydrochloride |
| 64764-890 | CONTRAVE | naltrexone hydrochloride and bupropion hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CONTRAVE 86026234 5181874 Live/Registered |
Orexigen Therapeutics, Inc. 2013-08-01 |
![]() CONTRAVE 78979619 3393576 Live/Registered |
NALPROPION PHARMACEUTICALS LLC 2006-01-06 |
![]() CONTRAVE 78794374 not registered Dead/Abandoned |
AGrow Tech LLC 2006-01-18 |
![]() CONTRAVE 78786858 not registered Dead/Abandoned |
Orexigen Therapeutics, Inc. 2006-01-06 |
![]() CONTRAVE 77926232 not registered Dead/Abandoned |
Orexigen Therapeutics, Inc. 2010-02-02 |
![]() CONTRAVE 77925784 not registered Dead/Abandoned |
Orexigen Therapeutics, Inc. 2010-02-02 |
![]() CONTRAVE 77811077 not registered Dead/Abandoned |
Orexigen Therapeutics, Inc. 2009-08-24 |